Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia

被引：3

作者：

Davis, Mellar ^{[1
]}

机构：

[1] Geisinger Med Ctr, Danville, PA 17822 USA

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2024年 / 68卷 / 01期

关键词：

D O I：

10.1016/j.jpainsymman.2024.03.019

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：e78 / e78

页数：1

共 7 条

[1] Transdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexia [J].

Alsirafy, Samy A. ;

Alabdullateef, Saad H. ;

Elyamany, Ashraf M. ;

Hassan, Amneh D. ;

Almashiakhi, Mohammed .

BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (E2) :E184-E186

[2] Cancer Cachexia May Hinder Pain Control When Using Fentanyl Patch [J].

Chiba, Takeshi ;

Takahashi, Hiroaki ;

Tairabune, Tomohiko ;

Kimura, Soichiro ;

Ueda, Hideo ;

Kudo, Kenzo .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (05) :873-878

[3] Transdermal fentanyl in cachectic cancer patients [J].

Heiskanen, Tarja ;

Matzke, Sorjo ;

Haakana, Soile ;

Gergov, Merja ;

Vuori, Erkki ;

Kalso, Eija .

PAIN, 2009, 144 (1-2) :218-222

[4] Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature [J].

Jackson, Lawrence D. ;

Wortzman, Rachel ;

Chua, Debbie ;

Selby, Debbie .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) :238-243

[5] Down-regulation of human CYP3A4 by the inflammatory signal interleukin 6:: molecular mechanism and transcription factors involved [J].

Jover, R ;

Bort, R ;

Gómez-Lechón, MJ ;

Castell, JV .

FASEB JOURNAL, 2002, 16 (11) :1799-+

[6]

Solassol I, 2005, ONCOL REP, V14, P1029

[7] Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients [J].

Suno, Manabu ;

Endo, Yuriko ;

Nishie, Hiroyuki ;

Kajizono, Makoto ;

Sendo, Toshiaki ;

Matsuoka, Junji .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 :751-757

← 1 →